Platelet-tolymphocyte ratio in patients with metastatic breast cancer treated with eribulin

被引：0
|
作者：
Shimada, Hiroko
Matsuura, Kazuo
Kohyama, Shunsuke
Asano, Aya
Ohara, Masahiro
Ishiguro, Hiroshi
Osaki, Akihiko
Saeki, Toshiaki
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO2-15-03
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO2-15-03
引用
收藏
页数：2
相关论文
共 50 条
  • [31] CORRELATION OF MALIGNANCY AND SENSITIVITY TO PRIOR TREATMENT IN METASTATIC BREAST CANCER TREATED WITH ERIBULIN
    Iwasa, T.
    Tsurutani, J.
    Matsuoka, H.
    Okamoto, K.
    Shimizu, T.
    Kurata, T.
    Nakagawa, K.
    Azumi, T.
    Hashimoto, Y.
    Komoike, Y.
    ANNALS OF ONCOLOGY, 2013, 24 : 36 - 36
  • [32] Interleukin-6 and C-Reactive protein in metastatic breast cancer patients treated with eribulin
    Altundag, Kadri
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 203 (03) : 627 - 627
  • [33] Safety and tolerability of eribulin mesylate in patients with pretreated metastatic breast cancer
    Goodin, Susan
    Barbour, Sally
    Song, James
    Berrak, Erhan
    Cox, David
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2015, 72 (24) : 2150 - 2156
  • [34] Eribulin mesylate as a microtubule inhibitor for treatment of patients with metastatic breast cancer
    Munoz-Couselo, Eva
    Perez-Garcia, Jose
    Cortes, Javier
    ONCOTARGETS AND THERAPY, 2011, 4 : 185 - 192
  • [35] Eribulin mesylate in the treatment of metastatic breast cancer
    Jain, Sarika
    Cigler, Tessa
    BIOLOGICS-TARGETS & THERAPY, 2012, 6 : 21 - 29
  • [36] Eribulin in metastatic breast cancer: our experience
    Prestifilippo, A.
    Puliafito, I.
    Grippaldi, D.
    Blanco, G.
    Memeo, L.
    Majorana, M.
    Giuffrida, D.
    ANNALS OF ONCOLOGY, 2015, 26 : 24 - 24
  • [37] Optimizing the timing of eribulin monotherapy for patients with metastatic breast cancer.
    Shingaki, Sumito
    Kogawa, Takahiro
    Shimokawa, Mototsugu
    Fujimoto, Yumi
    Harano, Kenichi
    Naito, Yoichi
    Matsubara, Nobuaki
    Matsui, Reiko
    Hosono, Ako
    Mukai, Hirofumi
    Mukohara, Toru
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [38] The Place for Eribulin in the Treatment of Metastatic Breast Cancer
    William J. Gradishar
    Current Oncology Reports, 2011, 13 : 11 - 16
  • [39] INDIRECT COSTS AMONG METASTATIC BREAST CANCER PATIENTS RECEIVING ERIBULIN
    Wan, Y.
    Copher, R.
    Corman, S.
    Abouzaid, S.
    Gao, X.
    VALUE IN HEALTH, 2015, 18 (03) : A202 - A202
  • [40] Incorporation of eribulin in the systemic treatment of metastatic breast cancer patients in Australia
    Chan, Arlene
    Lomma, Christopher
    Chih, HuiJun
    Blackely, Elizabeth
    Woodward, Natasha
    Tsoi, Daphne
    Cheong, Kerry
    Chipman, Mitchell
    Redfern, Andrew
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 (03) : 201 - 208
12345